Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Nonfasting triglycerides and risk of ischemic stroke in the general population.

Freiberg JJ, Tybjaerg-Hansen A, Jensen JS, Nordestgaard BG.

JAMA. 2008 Nov 12;300(18):2142-52. doi: 10.1001/jama.2008.621.

PMID:
19001625
2.

Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.

Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A.

JAMA. 2007 Jul 18;298(3):299-308.

PMID:
17635890
3.

[Nonfasting triglycerides and risk of ischemic stroke--secondary publication].

Freiberg JJ, Tybjaerg-Hansen A, Jensen JS, Nordestgaard BG.

Ugeskr Laeger. 2009 Jun 22;171(26):2188-91. Danish.

PMID:
19678435
4.

Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women.

Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM.

JAMA. 2007 Jul 18;298(3):309-16.

PMID:
17635891
5.

Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-up.

Langsted A, Freiberg JJ, Tybjaerg-Hansen A, Schnohr P, Jensen GB, Nordestgaard BG.

J Intern Med. 2011 Jul;270(1):65-75. doi: 10.1111/j.1365-2796.2010.02333.x. Epub 2010 Dec 27.

6.

Nonfasting triglycerides, cholesterol, and ischemic stroke in the general population.

Varbo A, Nordestgaard BG, Tybjaerg-Hansen A, Schnohr P, Jensen GB, Benn M.

Ann Neurol. 2011 Apr;69(4):628-34. doi: 10.1002/ana.22384. Epub 2011 Feb 18.

PMID:
21337605
7.

Remnant cholesterol as a causal risk factor for ischemic heart disease.

Varbo A, Benn M, Tybjærg-Hansen A, Jørgensen AB, Frikke-Schmidt R, Nordestgaard BG.

J Am Coll Cardiol. 2013 Jan 29;61(4):427-36. doi: 10.1016/j.jacc.2012.08.1026. Epub 2012 Dec 19.

8.

Plasma fasting and nonfasting triglycerides and high-density lipoprotein cholesterol in atherosclerotic stroke: different profiles according to low-density lipoprotein cholesterol.

Kim SJ, Park YG, Kim JH, Han YK, Cho HK, Bang OY.

Atherosclerosis. 2012 Aug;223(2):463-7. doi: 10.1016/j.atherosclerosis.2012.05.011. Epub 2012 May 19.

PMID:
22683121
9.

Genetically elevated lipoprotein(a) and increased risk of myocardial infarction.

Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG.

JAMA. 2009 Jun 10;301(22):2331-9. doi: 10.1001/jama.2009.801.

PMID:
19509380
10.

Major lipids, apolipoproteins, and risk of vascular disease.

Emerging Risk Factors Collaboration, Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, Wood AM, Lewington S, Sattar N, Packard CJ, Collins R, Thompson SG, Danesh J.

JAMA. 2009 Nov 11;302(18):1993-2000. doi: 10.1001/jama.2009.1619.

11.

Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study.

Shahar E, Chambless LE, Rosamond WD, Boland LL, Ballantyne CM, McGovern PG, Sharrett AR; Atherosclerosis Risk in Communities Study.

Stroke. 2003 Mar;34(3):623-31. Epub 2003 Feb 20.

12.

Triglycerides and risk of hemorrhagic stroke vs. ischemic vascular events: The Three-City Study.

Bonaventure A, Kurth T, Pico F, Barberger-Gateau P, Ritchie K, Stapf C, Tzourio C.

Atherosclerosis. 2010 May;210(1):243-8. doi: 10.1016/j.atherosclerosis.2009.10.043. Epub 2009 Nov 10.

PMID:
19963214
13.

Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation.

Varbo A, Benn M, Tybjærg-Hansen A, Nordestgaard BG.

Circulation. 2013 Sep 17;128(12):1298-309. doi: 10.1161/CIRCULATIONAHA.113.003008. Epub 2013 Aug 7.

14.

Extreme nonfasting remnant cholesterol vs extreme LDL cholesterol as contributors to cardiovascular disease and all-cause mortality in 90000 individuals from the general population.

Varbo A, Freiberg JJ, Nordestgaard BG.

Clin Chem. 2015 Mar;61(3):533-43. doi: 10.1373/clinchem.2014.234146. Epub 2015 Jan 20.

PMID:
25605681
15.
16.

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr.

JAMA. 1998 May 27;279(20):1615-22.

PMID:
9613910
17.

Loss-of-function mutations in APOC3 and risk of ischemic vascular disease.

Jørgensen AB, Frikke-Schmidt R, Nordestgaard BG, Tybjærg-Hansen A.

N Engl J Med. 2014 Jul 3;371(1):32-41. doi: 10.1056/NEJMoa1308027. Epub 2014 Jun 18.

18.

Nonfasting triglycerides and risk of cardiovascular death in men and women from the Norwegian Counties Study.

Lindman AS, Veierød MB, Tverdal A, Pedersen JI, Selmer R.

Eur J Epidemiol. 2010 Nov;25(11):789-98. doi: 10.1007/s10654-010-9501-1. Epub 2010 Oct 2.

19.

Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women.

Iso H, Sato S, Kitamura A, Imano H, Kiyama M, Yamagishi K, Cui R, Tanigawa T, Shimamoto T.

Stroke. 2007 Jun;38(6):1744-51. Epub 2007 Apr 12. Erratum in: Stroke. 2007 Jun;38(6):e37.

20.

A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction.

Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM, Hennekens CH.

JAMA. 1996 Sep 18;276(11):882-8.

PMID:
8782637
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk